 Aridis Pharmaceuticals, Inc. Nasdaq: ARDS, a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today its participation in Maxim Groups Infectious Disease Virtual Conference being held on May 5, 2020. Vu Truong, Ph.D., Chief Executive Officer, will be a speaker on two panels entitled Non-antibiotic Anti-infectives and COVID-19 Therapeutics. 